Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention
Top Cited Papers
Open Access
- 2 November 2011
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 3 (107), 107fs7
- https://doi.org/10.1126/scitranslmed.3002878
Abstract
Clinical studies should focus on prevention of Epstein-Barr virus–associated cancers and infectious mononucleosis, facilitated by identification of disease-predictive surrogate markers.Keywords
This publication has 9 references indexed in Scilit:
- Immune defence against EBV and EBV-associated diseaseCurrent Opinion in Immunology, 2011
- Epstein‐Barr virus and gastric carcinomaPathology International, 2010
- HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphomaProceedings of the National Academy of Sciences of the United States of America, 2010
- A Phase I Trial of Epstein-Barr Virus Gp350 Vaccine for Children With Chronic Kidney Disease Awaiting TransplantationTransplantation, 2009
- Phase I Trial of a CD8+T-Cell Peptide Epitope-Based Vaccine for Infectious MononucleosisJournal of Virology, 2008
- Recombinant gp350 Vaccine for Infectious Mononucleosis: A Phase 2, Randomized, Double‐Blind, Placebo‐Controlled Trial to Evaluate the Safety, Immunogenicity, and Efficacy of an Epstein‐Barr Virus Vaccine in Healthy Young AdultsThe Journal of Infectious Diseases, 2007
- The global health burden of infection‐associated cancers in the year 2002International Journal of Cancer, 2006
- Epstein–Barr Virus InfectionNew England Journal of Medicine, 2000
- Protection of cottontop tamarins against Epstein–Barr virus-induced malignant lymphoma by a prototype subunit vaccineNature, 1985